Kim Kiok, Shin Kyung-Min, Lee Jun-Hwan, Seo Bok-Nam, Jung So-Young, Youn Yousuk, Lee Sang Ho, Kim Jaehong, Qu Wenchun, Kim Tae-Hun
Department of Spine Center, Mokhuri Neck & Back Hospital, Seoul 06272, Republic of Korea.
Clinical Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea.
Evid Based Complement Alternat Med. 2016;2016:2913248. doi: 10.1155/2016/2913248. Epub 2016 Jan 28.
This is a study protocol for a pilot three-armed randomized controlled trial on nonsurgical integrative Korean medicinal treatment for symptomatic lumbar spinal stenosis (LSS). Thirty-six participants who have been diagnosed with (LSS) and recommended for spinal surgery by neurosurgeons or orthopedics and have had spinal symptoms such as severe low back pain and neurological claudication regardless of at least three months of conservative treatments will be recruited. Participants will be randomly assigned to be one of the three intervention groups, including the Mokhuri treatment program group 1 or 2 or usual care group. All treatments will be administered in inpatient units over a period of 4 weeks. The primary outcomes are 0 to 100 Visual Analogue Scales for low back pain and leg pain and the secondary outcomes are Oswestry Disability Index; EQ-5D; Roland-Morris Disability Questionnaire; Oxford Claudication Score; physical function test, including treadmill test, walking duration, and distance assessment for free leg pain; radiologic testing; and adverse events which will be assessed during the 4-week treatment period as well as after 3 and 6 months of follow-up. Then, we will assess the feasibility of the clinical trial design as well as a nonsurgical integrative treatment program. This trial is registered with CRIS registration number: KCT0001218.
这是一项关于非手术综合韩医治疗症状性腰椎管狭窄症(LSS)的三臂随机对照试验的研究方案。将招募36名已被诊断为LSS且经神经外科医生或骨科医生建议进行脊柱手术、无论经过至少三个月的保守治疗仍有严重腰痛和神经源性间歇性跛行等脊柱症状的参与者。参与者将被随机分配到三个干预组之一,包括莫库里治疗方案组1或2或常规护理组。所有治疗将在住院病房进行,为期4周。主要结局指标为0至100的腰痛和腿痛视觉模拟量表,次要结局指标为奥斯威斯残疾指数、EQ-5D、罗兰-莫里斯残疾问卷、牛津间歇性跛行评分、身体功能测试(包括跑步机测试、步行持续时间和自由腿痛距离评估)、放射学检查以及不良事件,这些将在4周治疗期以及随访3个月和6个月后进行评估。然后,我们将评估临床试验设计以及非手术综合治疗方案的可行性。本试验已在韩国临床试验信息服务系统(CRIS)注册,注册号为:KCT0001218。